Neuronascent, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers (NCT04074837) | Neuronascent, Inc. | 2019-08-01 |
Track Neuronascent, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.